HomeCompareRMED vs MO

RMED vs MO: Dividend Comparison 2026

RMED yields 336.70% · MO yields 6.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RMED wins by $3337.75M in total portfolio value
10 years
RMED
RMED
● Live price
336.70%
Share price
$0.59
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3337.83M
Annual income
$2,106,889,629.77
Full RMED calculator →
MO
Altria Group Inc.
● Live price
6.36%
Share price
$65.99
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.1K
Annual income
$30,159.17
Full MO calculator →

Portfolio growth — RMED vs MO

📍 RMED pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRMEDMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RMED + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RMED pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RMED
Annual income on $10K today (after 15% tax)
$28,619.53/yr
After 10yr DRIP, annual income (after tax)
$1,790,856,185.30/yr
MO
Annual income on $10K today (after 15% tax)
$540.99/yr
After 10yr DRIP, annual income (after tax)
$25,635.29/yr
At 15% tax rate, RMED beats the other by $1,790,830,550.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RMED + MO for your $10,000?

RMED: 50%MO: 50%
100% MO50/50100% RMED
Portfolio after 10yr
$1668.95M
Annual income
$1,053,459,894.47/yr
Blended yield
63.12%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

RMED
Analyst Ratings
2
Buy
3
Hold
Consensus: Hold
Altman Z
-31.7
Piotroski
2/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-7.2% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RMED buys
0
MO buys
0
No recent congressional trades found for RMED or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRMEDMO
Forward yield336.70%6.36%
Annual dividend / share$2.00$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.6%
Portfolio after 10y$3337.83M$80.1K
Annual income after 10y$2,106,889,629.77$30,159.17
Total dividends collected$3218.78M$74.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldBuy

Year-by-year: RMED vs MO ($10,000, DRIP)

YearRMED PortfolioRMED Income/yrMO PortfolioMO Income/yrGap
1← crossover$44,370$33,670.03$10,570$780.30+$33.8KRMED
2$187,097$139,620.61$11,381$1,032.90+$175.7KRMED
3$750,420$550,226.83$12,535$1,392.73+$737.9KRMED
4$2,865,463$2,062,513.01$14,193$1,920.91+$2.85MRMED
5$10,426,475$7,360,429.85$16,618$2,723.68+$10.41MRMED
6$36,186,404$25,030,075.51$20,263$3,993.80+$36.17MRMED
7$119,906,417$81,186,964.99$25,936$6,098.36+$119.88MRMED
8$379,719,698$251,419,831.96$35,166$9,775.01+$379.68MRMED
9$1,150,408,903$744,108,826.12$51,026$16,597.78+$1150.36MRMED
10$3,337,827,156$2,106,889,629.77$80,113$30,159.17+$3337.75MRMED

RMED vs MO: Complete Analysis 2026

RMEDStock

Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases. It offers destruction of arteriosclerotic blockages by laser radiation ablation, a minimally invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. The company sells its products primarily through distributors in the United States. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California.

Full RMED Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this RMED vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RMED vs SCHDRMED vs JEPIRMED vs ORMED vs KORMED vs MAINRMED vs PMRMED vs BTIRMED vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.